To prove the importance of theJAK pathway, someone needed to discover a compound to test the hypothesis that inhibiting theJAK enzyme was of value in treating disease.
Jacob Zenn, a Jamestown Foundation analyst who has researched JaK, told CNN the group has a track record of quickly and credibly claiming responsibility for attacks in Kazakhstan since its founding in September 2011.